Celltrio®, a pioneering life sciences company delivering advanced automation solutions for cell culturing and cell & gene therapy, today announced the closing of a $15 million financial investment round led by Premier Partners, a leading investor in healthcare innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610129377/en/ The new funding will accelerate the global commercialization of RoboCell®, Celltrio’s flagship ...